These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7713140)

  • 1. Potentiation by alcuronium of the antimuscarinic effect of N-methylscopolamine in guinea pig left atria.
    Maass A; Kostenis E; Mohr K
    Eur J Pharmacol; 1995 Jan; 272(1):103-6. PubMed ID: 7713140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. M2 receptor binding of the selective antagonist AF-DX 384: possible involvement of the common allosteric site.
    Tränkle C; Andresen I; Lambrecht G; Mohr K
    Mol Pharmacol; 1998 Feb; 53(2):304-12. PubMed ID: 9463489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposite effects of alcuronium on agonist and on antagonist binding to muscarinic receptors.
    Maass A; Mohr K
    Eur J Pharmacol; 1996 Jun; 305(1-3):231-4. PubMed ID: 8813558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing the specificity of allosteric modulators of muscarinic receptors in phylogenetically closely related histamine H1-receptors.
    Franken C; Tränkle C; Mohr K
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):107-12. PubMed ID: 10685864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric stabilization of 3H-N-methylscopolamine binding in guinea-pig myocardium by an antidote against organophosphate intoxication.
    Jepsen K; Lüllmann H; Mohr K; Pfeffer J
    Pharmacol Toxicol; 1988 Sep; 63(3):163-8. PubMed ID: 3054859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equipotent allosteric effect of W84 on [3H]NMS-binding to cardiac muscarinic receptors from guinea-pig, rat, and pig.
    Mohr K; Staschen CM; Ziegenhagen M
    Pharmacol Toxicol; 1992 Mar; 70(3):198-200. PubMed ID: 1579545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three allosteric modulators act at a common site, distinct from that of competitive antagonists, at muscarinic acetylcholine M2 receptors.
    Lanzafame A; Christopoulos A; Mitchelson F
    J Pharmacol Exp Ther; 1997 Jul; 282(1):278-85. PubMed ID: 9223565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C14-aminosteroid LNF 209, an agent with positive inotropic and antimuscarinic activity.
    Lüllmann H; Mohr K
    J Cardiovasc Pharmacol; 1992; 20(5):807-12. PubMed ID: 1280745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
    Tucek S; Musílková J; Nedoma J; Proska J; Shelkovnikov S; Vorlícek J
    Mol Pharmacol; 1990 Nov; 38(5):674-80. PubMed ID: 2233700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The allosteric interaction of otenzepad (AF-DX 116) at muscarinic M2 receptors in guinea pig atria.
    Lanzafame A; Christopoulos A; Mitchelson F
    Eur J Pharmacol; 2001 Mar; 416(3):235-44. PubMed ID: 11290374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive allosteric action of eburnamonine on cardiac muscarinic acetylcholine receptors.
    Proska J; Tucek S
    Eur J Pharmacol; 1996 Jun; 305(1-3):201-5. PubMed ID: 8813554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric modulation of muscarinic receptor signaling: alcuronium-induced conversion of pilocarpine from an agonist into an antagonist.
    Zahn K; Eckstein N; Tränkle C; Sadée W; Mohr K
    J Pharmacol Exp Ther; 2002 May; 301(2):720-8. PubMed ID: 11961078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of the hexamethonium derivative W84, an allosteric effector at muscarinic cholinoreceptors, with rat brain nicotinic binding sites.
    Leithäuser F; Mohr K; Staschen CM
    Pharmacol Toxicol; 1990 Oct; 67(4):317-21. PubMed ID: 2077524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a [3H]Ligand for the common allosteric site of muscarinic acetylcholine M2 receptors.
    Tränkle C; Mies-Klomfass E; Cid MH; Holzgrabe U; Mohr K
    Mol Pharmacol; 1998 Jul; 54(1):139-45. PubMed ID: 9658199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of cooperativity between N-methylscopolamine and allosteric modulators alcuronium and gallamine induced by mutations of external loops of muscarinic M(3) receptors.
    Krejcí A; Tucek S
    Mol Pharmacol; 2001 Oct; 60(4):761-7. PubMed ID: 11562438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive allosteric action of alcuronium on solubilized cardiac muscarinic receptors.
    Musílková J; Tucek S
    Neurochem Int; 1995; 27(4-5):337-43. PubMed ID: 8845734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergent modes of action among cationic allosteric modulators of muscarinic M2 receptors.
    Tränkle C; Mohr K
    Mol Pharmacol; 1997 Apr; 51(4):674-82. PubMed ID: 9106634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3H]N-methylscopolamine dissociation from muscarine receptors affected by low concentrations of allosteric modulators.
    Christopoulos A; Mitchelson F
    Eur J Pharmacol; 1995 Aug; 290(3):259-62. PubMed ID: 7589221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of an orthosteric agonist instead of an antagonist.
    Grossmüller M; Antony J; Tränkle C; Holzgrabe U; Mohr K
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan; 372(4):267-76. PubMed ID: 16362429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
    Jakubík J; Bacáková L; el-Fakahany EE; Tucek S
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1077-83. PubMed ID: 7562472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.